# Combination Therapy With Fluoroquinolone in Staphylococcus Aureus Bacteremia

> **NCT00548002** · — · COMPLETED · sponsor: **University of Helsinki** · enrollment: 430 (actual)

## Conditions studied

- Staphylococcus Aureus
- Bacteremia
- Endocarditis
- Sepsis

## Interventions

- **DRUG:** trovafloxacin and levofloxacin

## Key facts

- **NCT ID:** NCT00548002
- **Lead sponsor:** University of Helsinki
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 1999-01
- **Primary completion:** —
- **Final completion:** 2002-08
- **Target enrollment:** 430 (ACTUAL)
- **Last updated:** 2007-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00548002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00548002, "Combination Therapy With Fluoroquinolone in Staphylococcus Aureus Bacteremia". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00548002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*